KristenNooshinGanjooMD

Clinical Trials

• Bevacizumab and Combination Chemotherapy in Treating Patients With Peripheral T-Cell Lymphoma or Natural Killer Cell Neoplasms Start of enrollment: 2006 Sep 14

  Completed

  Phase 2

• Safety and Efficacy Study of an Anti-CD20 Monoclonal Antibody (AME-133v) to Treat Non-Hodgkin's Lymphoma Start of enrollment: 2006 Jul 01

  Completed

  Phase 1

• Safety and Efficacy Study of Glufosfamide in Previously Treated Advanced Soft Tissue Sarcoma Start of enrollment: 2007 Mar 01

  Completed

  Phase 2

• Dose-Escalation Study of TH-302 in Combination With Doxorubicin to Treat Patients With Advanced Soft Tissue Sarcoma Start of enrollment: 2008 Aug 01

  Completed

  Phase 1, Phase 2

• Paclitaxel + Bevacizumab (Avastin) for the Treatment of Metastatic or Unresectable Angiosarcoma Start of enrollment: 2010 Feb 01

  Terminated

  Phase 2

• Observational Study of Diffuse Large B Cell Primary Breast Lymphomas Treated With RCHOP +/- XRT Start of enrollment: 2009 Feb 01

  Terminated

• Nilotinib in Patients With Relapsed or Metastatic Pigmented Villonodular Synovitis/Tenosynovial Giant Cell Tumor/Diffuse-Type Giant Cell Tumor Start of enrollment: 2010 Sep 01

  Active, not recruiting

  Phase 2

• Cyclophosphamide, Doxorubicin, Vincristine w/ Irinotecan and Temozolomide in Ewings Sarcoma Start of enrollment: 2011 May 01

  Terminated

  Phase 2

• SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma Subtypes Start of enrollment: 2014 Jul 01

  Completed

  Phase 2

• Phase 3 Study to Treat Patients With Soft Tissue Sarcomas Start of enrollment: 2014 Jan 01

  Completed

  Phase 3

• A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma Start of enrollment: 2015 Sep 14

  Active, not recruiting

  Phase 3

• A Study of Ripretinib vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib Start of enrollment: 2019 Feb 08

  Active, not recruiting

  Phase 3

• Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma Start of enrollment: 2019 Aug 13

  Recruiting

  Phase 2

• Ipilimumab + Nivolumab + Cryotherapy in Metastatic or Locally Advanced Soft Tissue Sarcoma Start of enrollment: 2019 Oct 01

  Completed

  Phase 2

• 18F-FTC-146 PET/CT in Newly-Diagnosed Osteosarcoma Start of enrollment: 2021 Jan 28

  Terminated

  Phase 2

• Join now to see all